ALL-I-0143

N/A

Report date: 2025/01/26 18:16:15

Base Information

Drug NameALL-I-0143

Drug Alias Namebispecific cytokine targeting VHH domains (Allele Biotechnology)bispecific cytokine-targeting nanoantibodies (Allele Biotechnology)ALL-I-0143

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor α inhibitorsCytokine receptors antagonists

TargetsInterleukin 18 receptorTumor necrosis factor αCytokine receptors

Therapy Area/IndicationsInflammatory Bowel DiseasesSepsis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAllele Biotechnology and Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAllele Biotechnology and Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel DiseasesSepsis

Inactive IndicationsN/A

Other Information

ATC CodeN/A